Johannes Persch

Johannes Persch is a PhD candidate at the University of Mannheim in EU antitrust law and doctoral member of the Mannheim Centre for Competition and Innovation—MaCCI. His research is supported by a scholarship from the German National Academic Foundation. Johannes is qualified to practice law in Germany and holds an LL.M. from the University of Chicago Law School. Prior to starting his PhD, he has completed various internships, including at the German Federal Cartel Office, the European Commission and major international law firms. His work has been published in leading European and German journals, including the European Competition Journal, the Journal of European Competition Law and Pracice and Europarecht.

Should Google Still be Allowed to Crown the Kings in Digital Markets?

Google search is continuously evolving into a full service provider, directly selecting and presenting the information that we are looking for. At...

Latest news

The Aristocracy of Talent: Business Intelligence

In the following excerpt from his new book, The Aristocracy of Talent: How Meritocracy Made the Modern World, Adrian Wooldridge traces "how universities...

Why Privacy Experts Need a Place at the Antitrust Table

Antitrust enforcers have tended to stay narrowly “in their lane,” failing to engage with how data is collected and used by digital...

Assessing George Stigler’s Economic Theory of Regulation

Despite its flaws and limitations, Stigler’s seminal article on the theory of economic regulation remains an important piece of scholarship worthy of...

“Old Chicago” and Freiburg: Why Ordoliberalism Was No “German Oddity”

Both the Chicago and Freiburg schools faced systemic fragility as the crucial property of societal orders. It was this fragility that served...

The Many Faces of Stigler’s Theory of Economic Regulation: Interest Group Politics Still Thrives—But Industry Often Comes Second

Stigler treats industry groups as the heavyweights in regulatory contests. But surprisingly often groups of farmers and workers knock them for a...

Why the FTC Should Consider Size in Drug Mergers

Large pharmaceutical firms retain their dominance through size-related advantages in three areas: contracting, marketing and selling, and financing. When reviewing pharmaceutical mergers,...

In FTC vs. Facebook, the Government Lost the First Round. It Could Still Win the Fight.

Despite some compelling allegations, a federal judge dismissed the FTC's antitrust complaint against Facebook due to the agency’s failure to explain how...